Repository for Inherited Eye Diseases
Status: | Active, not recruiting |
---|---|
Conditions: | Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 2 - Any |
Updated: | 11/30/2018 |
Start Date: | September 11, 2006 |
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
This study will collect blood and DNA samples from patients with inherited eye diseases to be
used in research to identify genetic factors responsible for these conditions. In recent
years, nearly 500 genes that contribute to inherited eye diseases have been identified.
Disease-causing mutations are associated with many eye diseases, including glaucoma,
cataracts, strabismus, corneal dystrophies and a number of forms of retinal degenerations. As
a result, gene-based therapies are being pursued to treat eye genetic diseases that were once
considered untreatable.
The National Ophthalmic Genotyping Network (eyeGENE ) is creating a national tissue
repository to further advance genetic research on inherited eye disease, while at the same
time providing clinically-useful information back to patients and physicians who request it..
Physicians in collaborating institutions will recruit patients to participate in the study.
Patients will provide a blood sample and undergo a standard eye examination. The blood sample
and clinical information will then be sent to the NEI for testing, processing and storing in
the tissue repository. Patients are given the option to receive results back and/or to be
re-contacted in the event of future clinical studies. Information supplied to the testing
laboratories includes a unique identification number, the patient gender, and the patient
date of birth. The stored samples will be made available to researchers along with
information about the patient's disease, but without patient identifiers.
used in research to identify genetic factors responsible for these conditions. In recent
years, nearly 500 genes that contribute to inherited eye diseases have been identified.
Disease-causing mutations are associated with many eye diseases, including glaucoma,
cataracts, strabismus, corneal dystrophies and a number of forms of retinal degenerations. As
a result, gene-based therapies are being pursued to treat eye genetic diseases that were once
considered untreatable.
The National Ophthalmic Genotyping Network (eyeGENE ) is creating a national tissue
repository to further advance genetic research on inherited eye disease, while at the same
time providing clinically-useful information back to patients and physicians who request it..
Physicians in collaborating institutions will recruit patients to participate in the study.
Patients will provide a blood sample and undergo a standard eye examination. The blood sample
and clinical information will then be sent to the NEI for testing, processing and storing in
the tissue repository. Patients are given the option to receive results back and/or to be
re-contacted in the event of future clinical studies. Information supplied to the testing
laboratories includes a unique identification number, the patient gender, and the patient
date of birth. The stored samples will be made available to researchers along with
information about the patient's disease, but without patient identifiers.
Molecular genetics has the potential to revolutionize the diagnosis and treatment of
inherited eye diseases. Progress in research on inherited eye disease would be augmented by
the availability of patient DNA coupled to robust, anonymous phenotypic information. The
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE ) has been created to answer
this need. We propose the creation of a national DNA and blood repository for inherited eye
disease. These samples will be gathered from clinical centers around the nation and will be
coupled to anonymous, phenotypic descriptors. If requested, a portion of the sample submitted
by a clinician will be used for appropriate, CLIA-certified molecular diagnostics that can be
used in patient care. Once a sufficient repository is created, researchers will be able to
request aliquots for their laboratory experiments. Participants will be provided the option
to be re-contacted if an approved clinical study for which they might qualify is offered.
Researchers will be able to request aliquots for their laboratory experiments or ask the
eyeGENE Coordinating Center to re-contact participants to inform them about the possibility
to participate in a clinical study
inherited eye diseases. Progress in research on inherited eye disease would be augmented by
the availability of patient DNA coupled to robust, anonymous phenotypic information. The
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE ) has been created to answer
this need. We propose the creation of a national DNA and blood repository for inherited eye
disease. These samples will be gathered from clinical centers around the nation and will be
coupled to anonymous, phenotypic descriptors. If requested, a portion of the sample submitted
by a clinician will be used for appropriate, CLIA-certified molecular diagnostics that can be
used in patient care. Once a sufficient repository is created, researchers will be able to
request aliquots for their laboratory experiments. Participants will be provided the option
to be re-contacted if an approved clinical study for which they might qualify is offered.
Researchers will be able to request aliquots for their laboratory experiments or ask the
eyeGENE Coordinating Center to re-contact participants to inform them about the possibility
to participate in a clinical study
- INCLUSION CRITERIA:
To participate in this protocol:
1a. The participant must present with characteristics that meet minimal clinical criteria
established by eyeGENE, as determined by the referring clinician.
OR
1b. The participant must be a relative of an affected participant if analysis would help
with the interpretation of an affected participant's test results or to obtain some useful
information as decided by the eyeGENE Research Study Group.
2. The participant must be willing and able to provide a suitable blood sample.
EXCLUSION CRITERIA:
- Severe systemic disease that compromise the ability of the referring clinician to
obtain an adequate eye examination.
- Any disease or condition that makes it unsafe for a subject to provide a blood sample
of at least 5 ml for children and at least 15ml for adults.
- Inability to cooperate with phlebotomy and clinical examination.
- Those with impaired decision-making capability who do not have a legally-authorized
representative.
- If clinical criteria information, consent forms, or a blood sample can not be provided
by the doctor or participant after one year of submitting a blood sample to eyeGENE .
We found this trial at
33
sites
University of Utah Research is a major component in the life of the U benefiting...
Click here to add this to my saved trials
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
Click here to add this to my saved trials
Columbia University In 1897, the university moved from Forty-ninth Street and Madison Avenue, where it...
Click here to add this to my saved trials
Click here to add this to my saved trials
University of Michigan The University of Michigan was founded in 1817 as one of the...
Click here to add this to my saved trials
Click here to add this to my saved trials
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Massachusetts Eye & Ear Infirmary Whether you see our physicians at Mass. Eye and Ear's...
Click here to add this to my saved trials
Click here to add this to my saved trials
Univ of North Carolina Carolina’s vibrant people and programs attest to the University’s long-standing place...
Click here to add this to my saved trials
Children's Memorial Hospital, Chicago Ann & Robert H. Lurie Children
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
University of Texas Southwestern Medical Center UT Southwestern is an academic medical center, world-renowned for...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
Click here to add this to my saved trials
Click here to add this to my saved trials
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials